headerphoto

ConjuGon to Present at BIO 2007

05/02/2007

Madison, WI—ConjuGon® announces today that it was selected to present at the Business Forum at BIO 2007. BIO, the world’s largest biotechnology convention, will be held May 6-9, 2007 in Boston. BIO 2007 will feature biotechnology and pharmaceutical companies working to develop therapies for some of the world’s most devastating diseases and illnesses.

“We are excited to once again present at BIO. It is the premier biotechnology conference,” said ConjuGon’s COO Sal Braico. “We look forward to updating the biotechnology and pharmaceutical community about our therapeutic pipeline.”

ConjuGon is developing fundamentally new technologies to combat the growing epidemic of antibiotic-resistant bacteria. Antibiotic resistance is a medical crisis, globally responsible for hundreds of thousands of deaths each year. The company is located in the University Research Park in Madison.


Download pdf document

Latest News

news 23 Apr 2009
FDA Accepts IND for ConjuGon’s C-1205 — Prevention of Urinary Tract Infections

news 23 Oct 2008
ConjuGon to Receive $2.4 Million for Defense R&D

news 05 Dec 2007
ConjuGon to Receive $1.2 Million from Department of Defense